Intellipharmaceutics International Inc. | NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer (related to financial reporting)
Intellipharmaceutics International Inc. | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(0%),Steven Boyd(0%)
Intellipharmaceutics International Inc. | UPLOAD: Others
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Intellipharmaceutics International Inc. | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Intellipharmaceutics International Inc. | CORRESP: CORRESP
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer (related to financial reporting)
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer (related to financial reporting)
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer (related to financial reporting)
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer (related to financial reporting)
Intellipharmaceutics International Inc. | UPLOAD: Others
Intellipharmaceutics International Inc. | 20-F: FY2022 Annual Report
Intellipharmaceutics International Inc. | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer (related to financial reporting)
Intellipharmaceutics International Inc. | 6-K: Report of foreign private issuer (related to financial reporting)
No Data